Healthcare & Life Sciences Industry Updates

Google News – EMA (biotech/pharma) External News

EU expands Sobi's Aspaveli for rare kidney diseases - FirstWord Pharma

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

Apnimed dreams of IPO to fund launch of sleep apnea pill on FDA's desk - Fierce Biotech

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

Oncolytics Biotech Shares Rise on FDA Meeting Plan, Trial Progress in Colorectal Cancer - marketscreener.com

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca - Fierce Pharma

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

Longbio Pharma (Suzhou) Says FDA Approves Clinical Trial Application For LP-3 For Peanut Allergy - TradingView

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

Ascelia Pharma: FDA's clinical objections to Orviglance concern image-reading - marketscreener.com

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

[Analysis] FDA letters show manufacturing issue remains key hurdle for HLB liver cancer combo - koreabiomed.com

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA Warns Biotech Firm Over Cancer Drug Claims - Hematology Advisor

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA gene therapy regulator Vijay Kumar steps down from leadership role - Fierce Biotech

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

Pharma-backed petition calls on FDA to reform release of drug rejection letters - Endpoints News

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

Ascelia Pharma: Update on Orviglance NDA suggests clinical CRL concerns center on image reading - Inderes

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA releases 14 drug rejection letters after 3-month pause - Fierce Biotech

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny - Fierce Pharma

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA posts new rejection letters days after confirming pause - BioSpace

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

Oncolytics Biotech stock jumps on FDA meeting plans for trial - Investing.com

news.google.com · 14 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

EU expands Sobi's Aspaveli for rare kidney diseases - FirstWord Pharma

Apnimed dreams of IPO to fund launch of sleep apnea pill on FDA's desk - Fierce Biotech

Oncolytics Biotech Shares Rise on FDA Meeting Plan, Trial Progress in Colorectal Cancer - marketscreener.com

Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca - Fierce Pharma

Longbio Pharma (Suzhou) Says FDA Approves Clinical Trial Application For LP-3 For Peanut Allergy - TradingView

Ascelia Pharma: FDA's clinical objections to Orviglance concern image-reading - marketscreener.com

[Analysis] FDA letters show manufacturing issue remains key hurdle for HLB liver cancer combo - koreabiomed.com

FDA Warns Biotech Firm Over Cancer Drug Claims - Hematology Advisor

FDA gene therapy regulator Vijay Kumar steps down from leadership role - Fierce Biotech

Pharma-backed petition calls on FDA to reform release of drug rejection letters - Endpoints News

Ascelia Pharma: Update on Orviglance NDA suggests clinical CRL concerns center on image reading - Inderes

FDA releases 14 drug rejection letters after 3-month pause - Fierce Biotech

FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny - Fierce Pharma

FDA posts new rejection letters days after confirming pause - BioSpace

Oncolytics Biotech stock jumps on FDA meeting plans for trial - Investing.com